Parks Diane L. 4

What Happened

• Diane L. Parks, a director of Kura Oncology (KURA), was granted a derivative award on 2026-06-04 representing the right to acquire 35,000 shares. The filing reports an acquisition at $0.00 (no cash exchanged at grant). Footnote states the option vests in full on the one-year anniversary of the grant.

Key Details

• Transaction date: 2026-06-04; Transaction code: A (award/grant)
• Quantity: 35,000 shares; Reported price: $0.00 (derivative/option grant)
• Shares owned after transaction: Not specified in the filing
• Footnote: Option vests in full on the one-year anniversary of the grant (F1)
• Filing timeliness: Reported on 2026-06-04 for the same date — appears timely

Context

• This is a grant of an option-style award (a compensatory derivative), not a cash purchase or sale. Grants to directors are common as compensation and typically vest over time; they do not by themselves indicate buying or selling interest in the open market. The filing does not show an exercise price or immediate sale of shares — those details, if any, would appear in future filings.